• [email protected]
  • +61 8 9360 2888
Orthocell
  • Home
  • About
  • Team
  • Products
  • Invest
  • News
  • Practitioners
    • Striate+™
    • Remplir™
    • OrthoACI™
    • Tendon
  • Contact
  • Region
    • Visit AU – Home
    • Visit Americas
    • Visit EU/UK
  • Home
  • About
  • Team
  • Products
  • Invest
  • News
  • Practitioners
    • Striate+™
    • Remplir™
    • OrthoACI™
    • Tendon
  • Contact
  • Region
    • Visit AU – Home
    • Visit Americas
    • Visit EU/UK
30 Jun 2011
Orthocell Media Permalink

Stem cells show promise mending busted tendons

Orthocell 30 June 2011

Jill Margo, Health Editor at the Australian Financial Review, has published a feature article on Orthocell’s innovative autologous tenocyte implantation (ATI) therapy.

Read more

  • Recent posts

    • Orthocell achieves first Remplir™ sales in US$75 million Canadian Market
    • Remplir™ RWE study delivers 90% success rate
    • Orthocell reports continued growth and strong US momentum in March 2026 quarter
    • First Remplir™ Surgical Case Completed in U.S. Department of Defense Hospital Network 
    • Orthocell secures Remplir™ approval across U.S. Department of Defence Hospital Network
Next
  • © Orthocell Ltd. All rights reserved.

  • Contact Us

  • P: +61 8 9360 2888
    F: +61 8 9360 2899
    E: [email protected]

BUILT WITH ♡ BY H^CK Orthocell POWERED BY United Themes™
Please select the country you would like to view

Visit AU – Home

Visit Americas

Visit EU/UK

Join our mailing list

    By entering your email address you are agreeing to our privacy policy.


    Sign up to our EDM

    Patient expression of interest